The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers

Addiction

Volumn 108, Issue 11, 2013, Pages 1989-2000

  Schnoll, Robert A ^a   Goren, Amir ^b   Annunziata, Kathy ^b   Suaya, Jose A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KANTAR HEALTH   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Fagerstr m; Health care use; Heaviness of Smoking Index; Nicotine dependence; Productivity; Sensitivity and specificity; Time to first cigarette

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FAGERSTRÖM; FEMALE; HEALTH-CARE USE; HEAVINESS OF SMOKING INDEX; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PREVALENCE; PRODUCTIVITY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; STANDARD; STATISTICS; TIME TO FIRST CIGARETTE; TOBACCO DEPENDENCE; UNITED STATES; YOUNG ADULT; PSYCHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER;

FAGERSTRÖM; HEALTH-CARE USE; HEAVINESS OF SMOKING INDEX; NICOTINE DEPENDENCE; PRODUCTIVITY; SENSITIVITY AND SPECIFICITY; TIME TO FIRST CIGARETTE;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; TOBACCO USE DISORDER; UNITED STATES; YOUNG ADULT;

EID: 84885418407     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12285     Document Type: Article

References (51)

1. Cosci F., Corlando A., Fornai E., Pistelli F., Paoletti P., Carrozzi L. Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch. Addict Behav 2009; 34: 28-35.
2. Herrera N., Franco R., Herrera L., Partidas A., Rolando R., Fagerström K. O. Nicotine gum, 2 and 4mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995; 108: 447-451.
3. Hughes J. R., Rennard S. I., Fingar J. R., Talbot S. K., Callas P. W., Fagerström K. O. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res 2011; 13: 955-964.
4. Lerman C., Niaura R., Collins B. N., Wileyto P., Audrain-McGovern J., Pinto A. etal. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 2004; 18: 362-366.
5. Li M. D. The genetics of nicotine dependence. Curr Psychiatry Rep 2006; 8: 158-164.
6. Berrettini W. H., Doyle G. A. The CHRNA5-A3-B4 gene cluster in nicotine addiction. Mol Psychiatry 2012; 17: 856-866.
7. Bergen A. W., Conti D. V., Van Den Berg D., Lee W., Liu J., Li D. etal. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology 2009; 34: 2252-2264.
8. Li M. D. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum Genet 2008; 123: 119-131.
9. Shiffman S., Dresler C. M., Hajek P., Gilburt S. J., Targett D. A., Strahs K. R. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002; 162: 1267-1276.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association; 2000.
11. Fagerström K. A. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3: 235-241.
12. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerström K. A. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
13. Kozlowski L. T., Porter C. Q., Orleans T., Pope M. A., Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994; 34: 211-216.
14. Kozlowski L. T., Director J., Harford M. A. Tobacco dependence and time to first cigarette of the day. Addict Behav 1981; 6: 307-312.
15. Shiffman S., Waters A. J., Hickcox M. The Nicotine Dependence Syndrome Scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004; 6: 327-349.
16. Piper M. E., Piasecki T. M., Federman E. B., Bolt D. M., Smith S. S., Fiore M. C. etal. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol 2004; 72: 139-154.
17. Baker T. B., Piper M. E., McCarthy D. E., Bolt D. M., Smith S. S., Kim S. Y. etal. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007; 9: S555-570.
18. Luo Z., Alvarado G. F., Hatsukami D. K., Johnson E. O., Bierut L. J., Breslau N. Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). Nicotine Tob Res 2008; 10: 1223-1230.
19. Haberstick B. C., Timberlake D., Ehringer M. A., Lessem J. M., Hopfer C. J., Smolen A. etal. Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 2007; 102: 655-665.
20. Muscat J. E., Stellman S. D., Caraballo R. S., Richie J. P. Jr. Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev 2009; 18: 3415-3420.
21. Cox L. S., Faseru B., Mayo M. S., Krebill R., Snow T. S., Bronars C. A. etal. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. Trials 2011; 12: 22-34.
22. Campbell D. T., Fiske D. W. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959; 56: 81-105.
23. DiBonaventura M. D., Wagner J., Yuan Y., L'Italien G., Langley P., Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ 2010; 13: 709-718.
24. Bolge S. C., Doan J. F., Kannan H., Baran R. W. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009; 18: 415-422.
25. Fagerström K., Russ C., Yu C. R., Yunis C., Foulds J. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res 2012; 14: 1467-1473.
26. de Leon J., Diaz F. J., Becoña E., Gurpegui M., Jurado D., Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav 2003; 28: 1481-1486.
27. Mikami I., Akechi T., Kugaya A., Okuyama T., Nakano T., Okamura H. etal. Screening for nicotine dependence among smoking-related cancer patients. Jpn J Cancer Res 1999; 90: 1071-1075.
28. Osório Fde L., de Carvalho A. C., Crippa J. A., Loureiro S. R. Screening for smoking in a general hospital: scale validation, indicators of prevalence, and comorbidity. Perspect Psychiatr Care 2013; 49: 5-12.
29. Garvey A. J., Kinnunen T., Nordstrom B. L., Utman C. H., Doherty K., Rosner B. etal. Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tob Res 2000; 2: 53-63.
30. Bauld L., Chesterman J., Ferguson J., Judge K. A comparison of the effectiveness of group-based and pharmacy-led smoking cessation treatment in Glasgow. Addiction 2009; 104: 308-316.
31. Ware J. Jr, Kosinski M., Keller S. D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
32. Sobotova L., Liu Y. H., Burakoff A., Sevcikova L., Weitzman M. Household exposure to secondhand smoke is associated with decreased physical and mental health of mothers in the USA. Matern Child Health J 2011; 15: 128-137.
33. Reilly M. C., Zbrozek A. S., Dukes E. M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353-365.
34. Tang K., Beaton D. E., Boonen A., Gignac M. A., Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care Res (Hoboken) 2011; 63: S337-349.
35. Chung T., Martin C. S., Maisto S. A., Cornelius J. R., Clark D. B. Greater prevalence of proposed DSM-5 nicotine use disorder compared to DSM-IV nicotine dependence in treated adolescents and young adults. Addiction 2012; 107: 810-818.
36. Pulay A. J., Stinson F. S., Ruan W. J., Smith S. M., Pickering R. P., Dawson D. A. etal. The relationship of DSM-IV personality disorders to nicotine dependence-results from a national survey. Drug Alcohol Depend 2010; 108: 141-145.
37. Hendricks P. S., Prochaska J. J., Humfleet G. L., Hall S. M. Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction 2008; 103: 1215-1223.
38. Donny E. C., Dierker L. C. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend 2007; 89: 93-96.
39. Hu M. C., Davies M., Kandel D. B. Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am J Public Health 2006; 96: 299-308.
40. Fidler J. A., Shahab L., West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction 2011; 106: 631-638.
41. King B. A., Dube S. R., Tynan M. A. Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Am J Public Health 2012; 102: e93-100.
42. Goodwin R. D., Pagura J., Spiwak R., Lemeshow A. R., Sareen J. Predictors of persistent nicotine dependence among adults in the United States. Drug Alcohol Depend 2011; 118: 127-133.
43. Hiscock R., Bauld L., Amos A., Fidler J. A., Munafò M. Socioeconomic status and smoking: a review. Ann NY Acad Sci 2012; 1248: 107-123.
44. Fine L. J., Philogene G. S., Gramling R., Coups E. J., Sinha S. Prevalence of multiple chronic disease risk factors. 2001 National Health Interview Survey. Am J Prev Med 2004; 27: 18-24.
45. McClure J. B., Catz S. L., Ludman E. J., Richards J., Riggs K., Grothaus L. Feasibility and acceptability of a multiple risk factor intervention: the Step Up randomized pilot trial. BMC Public Health 2011; 11: 167.
46. Zvolensky M. J., Jenkins E. F., Johnson K. A., Goodwin R. D. Personality disorders and cigarette smoking among adults in the United States. J Psychiatr Res 2011; 45: 835-841.
47. Swendsen J., Conway K. P., Degenhardt L., Glantz M., Jin R., Merikangas K. R. etal. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010; 105: 1117-1128.
48. Schmitz N., Kruse J., Kugler J. Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. Am J Psychiatry 2003; 160: 1670-1676.
49. Davila E. P., Zhao W., Byrne M., Hooper M. W., Messiah A., Caban-Martinez A. etal. Health-related quality of life and nicotine dependence, Florida 2007. Am J Health Behav 2011; 35: 280-289.
50. Fishman A., Khan Z., Thompson E., Curry S. Health care costs among smokers, former smokers, and never smokers in an HMO 2003. Health Serv Res 2003; 38: 733-749.
51. Courvoisier D. S., Etter J. F. Comparing the predictive validity of five cigarette dependence questionnaires. Drug Alcohol Depend 2010; 107: 128-133.